Amarantus Bioscience Holdings Stock Buy Hold or Sell Recommendation
| AMBS Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Amarantus Bioscience Holdings is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Amarantus Bioscience Holdings given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Amarantus Bioscience Holdings, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Amarantus Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Amarantus and provide practical buy, sell, or hold advice based on investors' constraints. Amarantus Bioscience Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Amarantus |
Execute Amarantus Bioscience Buy or Sell Advice
The Amarantus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Amarantus Bioscience Holdings. Macroaxis does not own or have any residual interests in Amarantus Bioscience Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Amarantus Bioscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Buy
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Amarantus Bioscience Trading Alerts and Improvement Suggestions
| Amarantus Bioscience is way too risky over 90 days horizon | |
| Amarantus Bioscience has some characteristics of a very speculative penny stock | |
| Amarantus Bioscience appears to be risky and price may revert if volatility continues | |
| Amarantus Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| Amarantus Bioscience Holdings currently holds 20.72 M in liabilities with Debt to Equity (D/E) ratio of 0.84, which is about average as compared to similar companies. Amarantus Bioscience has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Amarantus Bioscience until it has trouble settling it off, either with new capital or with free cash flow. So, Amarantus Bioscience's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amarantus Bioscience sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amarantus to invest in growth at high rates of return. When we think about Amarantus Bioscience's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (10.58 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Amarantus Bioscience Holdings currently holds about 178 in cash with (1.8 M) of positive cash flow from operations. | |
| Latest headline from zacks.com: Nutanix is Attracting Investor Attention Here is What You Should Know |
Amarantus Bioscience Returns Distribution Density
The distribution of Amarantus Bioscience's historical returns is an attempt to chart the uncertainty of Amarantus Bioscience's future price movements. The chart of the probability distribution of Amarantus Bioscience daily returns describes the distribution of returns around its average expected value. We use Amarantus Bioscience Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Amarantus Bioscience returns is essential to provide solid investment advice for Amarantus Bioscience.
| Mean Return | 21.29 | Value At Risk | -50 | Potential Upside | 100.00 | Standard Deviation | 50.01 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Amarantus Bioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Amarantus Bioscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Amarantus Bioscience or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Amarantus Bioscience's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Amarantus pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 21.08 | |
β | Beta against Dow Jones | 9.02 | |
σ | Overall volatility | 128.83 | |
Ir | Information ratio | 0.17 |
Amarantus Bioscience Volatility Alert
Amarantus Bioscience Holdings is displaying above-average volatility over the selected time horizon. Amarantus Bioscience Holdings appears to be a penny stock. Although Amarantus Bioscience Holdings may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Amarantus Bioscience Holdings or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Amarantus instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Amarantus Bioscience Fundamentals Vs Peers
Comparing Amarantus Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Amarantus Bioscience's direct or indirect competition across all of the common fundamentals between Amarantus Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Amarantus Bioscience or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Amarantus Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Amarantus Bioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Amarantus Bioscience to competition |
| Fundamentals | Amarantus Bioscience | Peer Average |
| Current Valuation | 6.59 M | 16.62 B |
| Shares Outstanding | 68.27 M | 571.82 M |
| Price To Earning | (0.01) X | 28.72 X |
| Price To Book | 53.19 X | 9.51 X |
| EBITDA | (20.79 M) | 3.9 B |
| Net Income | (10.58 M) | 570.98 M |
| Cash And Equivalents | 178 | 2.7 B |
| Total Debt | 20.72 M | 5.32 B |
| Debt To Equity | 0.84 % | 48.70 % |
| Current Ratio | 0.02 X | 2.16 X |
| Book Value Per Share | (0.12) X | 1.93 K |
| Cash Flow From Operations | (1.8 M) | 971.22 M |
| Earnings Per Share | (0.03) X | 3.12 X |
| Target Price | 9.0 | |
| Number Of Employees | 19 | 18.84 K |
| Beta | 1.67 | -0.15 |
| Market Capitalization | 3.13 M | 19.03 B |
| Total Asset | 3.48 M | 29.47 B |
| Retained Earnings | (104.87 M) | 9.33 B |
| Working Capital | (14.89 M) | 1.48 B |
| Current Asset | 942 K | 9.34 B |
| Current Liabilities | 15.83 M | 7.9 B |
| Z Score | -63.3 | 8.72 |
| Net Asset | 3.48 M |
Amarantus Bioscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Amarantus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Amarantus Bioscience Buy or Sell Advice
When is the right time to buy or sell Amarantus Bioscience Holdings? Buying financial instruments such as Amarantus Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Amarantus Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Management Thematic Idea Now
Management
Companies providing management services to businesses. The Management theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Management Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Amarantus Pink Sheet Analysis
When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.